(Q34186679)

English

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia.

scientific article

Statements

Phase 2 study of rituximab in the treatment of cladribine-failed patients with hairy cell leukemia (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit